Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now small index

Hearing Loss, Unilateral clinical trials

4 of 5 indexed Hearing Loss, Unilateral trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 4 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Hearing Loss, Unilateral: 5 US clinical trials tracked, 4 recruiting.

Hearing Loss, Unilateral is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. The most active sponsor is Med-El Corporation, running 1 of these trials.

Enrollment posture brief

Registry condition hearing-loss-unilateral

OPEN 4 | RECR 80% | LATE 0 | EARLY 0 | RANK #3391 | SPON 1

Nearest open-share peer: Acute Leukemia of Ambiguous Lineage (80% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Hearing Loss, Unilateral (th…80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Hearing Loss, Unilateral

Hearing Loss, Unilateral lists 4 open slots (80% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hearing Loss, Unilateral on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hearing Loss, Unilateral is recruiting above its size-band peers.

    4 of 5 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Hearing Loss, Unilateral research.

    Med-El Corporation accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Hearing Loss, Unilateral trials plan to enrol fewer than 100 people.

    Median target enrolment is 60 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.

  4. Hearing Loss, Unilateral research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Hearing Loss, Unilateral records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Subjective Questionnaire Other
1 trials
Personal remote microphone (RM) system Device
1 trials
MED-EL Cochlear Implant System Device
1 trials
Pure Tone Audiometry Other
1 trials
Otoacoustic Emissions Testing Other
1 trials
Cochlear Implant Device
1 trials
The Cochlear™ Nucleus® Cochlear Implant (CI) System Device
1 trials

US sites by state

Facility locations filed on Hearing Loss, Unilateral trials. A trial with sites in several states counts in each.

North Carolina 3 trials
Washington 2 trials
New York 2 trials
Iowa 2 trials
California 2 trials
Texas 1 trials
Ohio 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hearing Loss, Unilateral page

5 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 4 Hearing Loss, Unilateral trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Med-El Corporation sponsors the most Hearing Loss, Unilateral trials on record, review their full trial history before evaluating a specific study. See Med-El Corporation's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hearing Loss, Unilateral condition card totals 5 registered trials; most-linked intervention Subjective Questionnaire; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.